ARSArs Technica·2dHealth
score-0.50
FDA Scientists Note Absence of Proof for Safety or Efficacy of Popular Peptides Amid RFK Jr. Proposal
Original
RFK Jr. proposes FDA look the other way on unproven peptides, report says
“The headline frames regulatory inaction as a dangerous concession, emphasizing public health risks associated with unproven substances.”